Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs...
Leadership
Frank Isaac Litvack FACC, M.D.
Executive Chairman of the Board
Linda Marbán Ph.D.Founder
Co-Founder, President, CEO & Director
Anthony J. Bergmann M.B.A.
CFO & Corporate Treasurer
Karen G. Krasney Esq., J.D.
Executive VP, General Counsel & Secretary
Kristi A. H. Elliott Ph.D.
Chief Operating & Science Officer
Minghao Sun Ph.D.
Senior Vice President of Quality Control, Research & Product Development
Mark Awadalla
Chief Development Officer
Micheal Binks M.D.
Chief Medical Officer
Nathaniel Hogan Ph.D.
Director of Biostatistics of Capricor Therapeutics
